| scholarly article | Q13442814 |
| P50 | author | Dennis R. Taaffe | Q37835012 |
| Sarianna Sipilä | Q40400716 | ||
| P2093 | author name string | Cheng S | |
| Toivanen J | |||
| Puolakka J | |||
| Suominen H | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | placebo | Q269829 |
| Hormone Replacement Therapy | Q108667313 | ||
| P304 | page(s) | 147-157 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Clinical Science | Q372419 |
| P1476 | title | Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. | |
| P478 | volume | 101 |
| Q90164928 | 17β-estradiol alters mRNA co-expression after murine muscle injury and mild hypobaria |
| Q92954505 | Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis |
| Q31146755 | Associations of hormone replacement therapy with bone structure and physical performance among postmenopausal women. |
| Q34666496 | Benefits of estrogen replacement for skeletal muscle mass and function in post-menopausal females: evidence from human and animal studies |
| Q35667577 | Body composition and muscle performance during menopause and hormone replacement therapy. |
| Q33324397 | Catechol-o-methyltransferase gene polymorphism is associated with skeletal muscle properties in older women alone and together with physical activity |
| Q58701762 | Design and protocol of Estrogenic Regulation of Muscle Apoptosis (ERMA) study with 47 to 55-year-old women's cohort: novel results show menopause-related differences in blood count |
| Q33206783 | Determinants of changes in bone mass and femoral neck structure, and physical performance after menopause: a 9-year follow-up of initially peri-menopausal women |
| Q33688278 | Does quadriceps neuromuscular activation capability explain walking speed in older men and women? |
| Q61448175 | Effect of Estrogen on Musculoskeletal Performance and Injury Risk |
| Q34348683 | Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials |
| Q35667580 | Effects of estrogen replacement on metabolic factors that influence physical performance in female hypogonadism |
| Q44360242 | Effects of exercise training and hormone replacement therapy on lean and fat mass in postmenopausal women |
| Q44908447 | Effects of ovariectomy and estrogen on skeletal muscle function in growing rats |
| Q51613697 | Effects of ovariectomy and resistance training on MMP-2 activity in skeletal muscle. |
| Q51382728 | Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: a 6-month double-blind controlled trial. |
| Q36718533 | Efficacy of tibolone and raloxifene for the maintenance of skeletal muscle strength, bone mineral density, balance, body composition, cognitive function, mood/depression, anxiety and quality of life/well-being in late postmenopausal women >/= 70 yea |
| Q46925977 | Endogenous hormones, muscle strength, and risk of fall-related fractures in older women |
| Q35097825 | Estradiol treatment, physical activity, and muscle function in ovarian-senescent mice |
| Q38264049 | Estrogen influences on neuromuscular function in postmenopausal women. |
| Q33891395 | Estrogen replacement and skeletal muscle: mechanisms and population health |
| Q30090708 | Estrogens in Male Physiology |
| Q31117448 | Exercise for health for early postmenopausal women: a systematic review of randomised controlled trials |
| Q44021590 | Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement |
| Q90006370 | Gestational Exposure to Bisphenol A and Bisphenol S Leads to Fetal Skeletal Muscle Hypertrophy Independent of Sex |
| Q37507044 | Hormone replacement and strength training positively influence balance during gait in post-menopausal females: a pilot study |
| Q35093102 | Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-223 expressions: a study on postmenopausal monozygotic twin pairs |
| Q46303614 | Hormone replacement therapy improves contractile function and myonuclear organization of single muscle fibres from postmenopausal monozygotic female twin pairs. |
| Q37332522 | Hormone therapy and skeletal muscle strength: a meta-analysis. |
| Q38124296 | How sex hormones promote skeletal muscle regeneration |
| Q38511940 | Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome |
| Q33302792 | Interaction between playing golf and HRT on vertebral bone properties in post-menopausal women measured by QCT. |
| Q35192141 | Intramuscular sex steroid hormones are associated with skeletal muscle strength and power in women with different hormonal status |
| Q39124487 | Morphological and functional characteristics of skeletal muscle fibers from hormone-replaced and nonreplaced postmenopausal women. |
| Q37502104 | Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons. |
| Q89526187 | Muscle and bone mass in middle-aged women: role of menopausal status and physical activity |
| Q51400712 | Muscle function in monozygotic female twin pairs discordant for hormone replacement therapy. |
| Q55040833 | Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. |
| Q35048460 | Muscle performance, sex hormones and training in peri-menopausal and post-menopausal women. |
| Q34121822 | Optimal management of sarcopenia |
| Q47725934 | Physical Activity and Nutrition INfluences In ageing (PANINI): consortium mission statement. |
| Q81470823 | Power output, isometric strength and steadiness in the leg muscles of pre- and postmenopausal women; the effects of hormone replacement therapy |
| Q34080414 | Power training and postmenopausal hormone therapy affect transcriptional control of specific co-regulated gene clusters in skeletal muscle. |
| Q60714026 | Regulation of the STARS signaling pathway in response to endurance and resistance exercise and training |
| Q37965428 | Sex hormone replacement in Turner syndrome. |
| Q38103483 | Sex hormones and skeletal muscle weakness |
| Q51788356 | Sex- and age-related differences in mid-thigh composition and muscle quality determined by computed tomography in middle-aged and elderly Japanese. |
| Q28081545 | Sex-based differences in skeletal muscle kinetics and fiber-type composition |
| Q36288095 | Sex-related differences in gene expression in human skeletal muscle |
| Q35195120 | Similarities in acquired factors related to postmenopausal osteoporosis and sarcopenia |
| Q89696123 | The Impact of Skeletal Muscle ERα on Mitochondrial Function and Metabolic Health |
| Q38190031 | The STARS signaling pathway: a key regulator of skeletal muscle function. |
| Q53359801 | The effect of exercise on physical fitness and quality of life in postmenopausal women. |
| Q46665410 | The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a yearlong intervention |
| Q33514763 | The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women |
| Q27008819 | The effect of physiological stimuli on sarcopenia; impact of Notch and Wnt signaling on impaired aged skeletal muscle repair |
| Q64355661 | The impact of ERα action on muscle metabolism and insulin sensitivity - Strong enough for a man, made for a woman |
| Q37658641 | The influence of estrogen on skeletal muscle: sex matters |
| Q36460888 | The regulation and function of the striated muscle activator of rho signaling (STARS) protein. |
| Q36864744 | The role of estrogens in control of energy balance and glucose homeostasis |
| Q35971744 | Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging. |
| Q37955979 | Translational musculoskeletal science: is sarcopenia the next clinical target after osteoporosis? |
| Q37573464 | Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia |
Search more.